|
시장보고서
상품코드
1747566
분자 이미징 시장 : 제품 유형별, 소프트웨어 플랫폼별, 용도별, 최종 사용자별, 지역별Molecular Imaging Market, By Product Type, Software Platforms, By Application, By End User, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 분자 이미징 시장은 2025년에 53억 2,000만 달러로 추정되고, 2032년에는 77억 9,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 CAGR은 5.6%를 나타낼 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 53억 2,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간 CAGR(2025-2032년) | 5.60% | 예측 금액(2032년) | 77억 9,000만 달러 |
분자 이미징은 의료용 이미징의 한 분야이며, 살아있는 환자의 의료적 관심 분자를 이미징하는 데 초점을 맞추었습니다. 심장혈관, 신경, 종양, 호흡기, 소화기 등 폭넓은 질환의 진단과 관리에 이용됩니다. 분자 이미징은 핵의학의 한 분야입니다.
시장 역학
분자 이미징법은 다양한 유형의 암에 대한 표준치료의 일부가 되고 있습니다. 따라서, 조기 진단에 대한 의식 증가는 양전자 방사선 단층 촬영(PET), 단광자 방사선 컴퓨터 단층 촬영(SPECT), 양전자 방사선 단층 촬영, 컴퓨터 단층 촬영(PET- CT), 단광자 방사 컴퓨터 단층 촬영-컴퓨터 단층 촬영(SPECT-CT) 등의 진단 제품에 대한 수요를 밀어 올 가능성이 높습니다. 이것이, 세계의 분자 이미징 시장 성장을 가속할 것으로 기대되고 있습니다. 예를 들어, 2021년 6월 진단 영상 시스템의 선도적 공급업체인 캐논 메디컬 시스템즈(Canon Medical Systems USA Inc.)는 카테시온 프라임 디지털 PET/CT 시스템에 사용되는 딥러닝 재구성(DLR) 기술 및 고급 지능형 클리어-IQ 엔진(AiCE)이 미국 식품의약국(FDA)으로부터 510(k) 허가를 획득했습니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 분자 이미징 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모·CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝혀 이 시장의 매력적인 투자 제안의 매트릭스에 대해 설명하고 있습니다.
- 또, 시장 성장 촉진요인 및 억제요인이나 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 세계의 분자 이미징 시장에 있어서 주요 기업 프로파일을, 기업 개요, 제품 포트폴리오, 주요한 하이라이트, 재무 실적, 전략 등의 이하의 파라미터에 근거해 제공합니다.
- 본 보고서의 인사이트를 이용해, 마케팅 담당자나 기업의 경영진이, 향후 제품 발매·제휴·시장 확대·마케팅 전술에 관한, 충분한 정보에 근거한 의사 결정을 내릴 수 있습니다.
- 「세계의 분자 이미징 시장」보고서는 투자자, 공급자, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등, 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
- 이해관계자는 세계의 분자 이미징 시장 분석에 사용되는 다양한 전략 매트릭스를 통해, 의사 결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학·규제·동향의 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 하이라이트
- 역학
- 기업 합병·인수(M&A), 사업 협력
- 규제 시나리오
- 주요 발전
- PEST 분석
제4장 세계의 분자 이미징 시장 : 신형 코로나 바이러스 감염증(COVID-19) 유행의 영향
- COVID-19의 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 세계의 분자 이미징 시장 : 제품 유형별(2020-2032년)
- 디바이스
- 소프트웨어 플랫폼
제6장 세계의 분자 이미징 시장 : 용도별(2020-2032년)
- 심혈관
- 신경학
- 종양학
- 호흡기
- 위장
- 기타 용도
제7장 세계의 분자 이미징 시장 : 최종 사용자별(2020-2032년)
- 병원
- 진단 이미지 센터
- 외래수술센터(ASC)
제8장 세계의 분자 이미징 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙 아프리카
- 남아프리카
제9장 경쟁 구도
- 기업 프로파일
- GE Healthcare
- Bruker Corporation
- Fujifilm Holdings Corp.
- Siemens Healthineers
- Koninklijke Philips NV
- Canon Medical Systems Corporation
- United Imaging Healthcare Co. Ltd.
- Mediso Kft.
- Positron Corporation
- Esaote SpA
- Carestream Health
- Mirada Medical Limited
- Hermes Medical Solutions
제10장 섹션
- 참고문헌
- 분석 방법
Global molecular imaging market is estimated to be valued at USD 5.32 Bn in 2025 and is expected to reach USD 7.79 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 5.32 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.60% | 2032 Value Projection: | USD 7.79 Bn |
Molecular imaging is an area of medical imaging that focuses on imaging molecules of medical concern in living patients. It is integrated advanced imaging technology with molecular and cellular biology. It is safe, noninvasive, and painless procedure that is used to diagnose and manage a wide range of diseases such as cardiovascular, neurology, oncology, respiratory, and gastrointestinal. Molecular imaging is field of nuclear medicine. It includes small amount of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Moreover, molecular imaging helps to physician to disease management and improve personalize patient care.
Market Dynamics
Molecular imaging has become a part of the standard care for various types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has significantly impacted the clinical management of cancer. Thus, increasing awareness of the early diagnosis is likely to boost the demand for diagnostic products such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), positron emission tomography-computed tomography (PET-CT), single-photon emission computed tomography-computed tomography (SPECT-CT), etc. This, in turn, is expected to drive the global molecular imaging market growth. Moreover, a surge in the adoption of technologically advanced products is expected to drive the market growth. For instance, in June 2021, a leading provider of diagnostic imaging systems Canon Medical Systems USA Inc. a leading provider of diagnostic imaging systems, deep Learning Reconstruction (DLR) technology and Advanced intelligent Clear-IQ Engine (AiCE), both used in Cartesion Prime Digital PET/CT system, received 510(k) clearance from the U.S. Food and Drugs Administration (FDA). The Cartesion Prime with AiCE help clinicians consistently and routinely produce high-quality images.
Key features of the study:
- This report provides an in-depth analysis of the global molecular imaging market, market size (US$ Bn), and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global molecular imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
- Key companies covered as a part of this study include GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, UNITED IMAGING HEALTHCARE CO., LTD., Mediso kft., Positron Corporation, ESAOTE S.P.A., Carestream Health, Mirada Medical Limited, and Hermes Medical Solutions
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global molecular imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular imaging market.
Market Segmentation
- Global Molecular Imaging Market, By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography- Computed Tomography (PET-CT)
- Positron Emission Tomography- Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- Global Molecular Imaging Market, By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- Global Molecular Imaging Market, By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Global Molecular Imaging Market, By Region:
- North America
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- U.S.
- Canada
- Latin America
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- GE Healthcare
- Bruker Corporation
- Fujifilm Holdings Corp.
- Siemens Healthineers
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
- Mediso kft.
- Positron Corporation
- ESAOTE S.P.A.
- Carestream Health
- Mirada Medical Limited
- Hermes Medical Solutions
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Molecular Imaging Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Molecular Imaging Market, By Product Type, 2020- 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products ( Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography- Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR))
- Software Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- On Premises Solutions
- Cloud Based Solutions
6. Global Molecular Imaging Market, By Application, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
7. Global Molecular Imaging Market, By End User, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Others
8. Global Molecular Imaging Market, By Region, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Region/Country, 2020 -2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bruker Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Fujifilm Holdings Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Siemens Healthineers
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Koninklijke Philips N.V.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Canon Medical Systems Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- United Imaging Healthcare Co., Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Mediso Kft.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Positron Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Esaote SpA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Carestream Health
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Mirada Medical Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Hermes Medical Solutions
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- GE Healthcare
10. Section
- References
- Research Methodology
- About us and Sales Contact
샘플 요청 목록